IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Vhcp Management, LLC

Q3 2013 Holdings

Filed 2013-11-15 | 18 holdings | $16.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
BioCryst Pharmaceuticals Inc(BCRX)COM09058V103$15.9M2,180,65699.0%
Dyax CorpCOM26746E103$28.5K4,156,5080.2%
Ironwood Pharmaceuticals Inc(IRWD)COM46333X108$21.3K1,800,0000.1%
Keryx Biopharmaceuticals IncCOM492515101$20.7K2,048,7730.1%
Anacor Pharmaceuticals IncCOM032420101$17.1K1,610,8560.1%
GW PharmaceuticalsCOM36197T103$14.5K837,8000.1%
Neurocrine Biosciences Inc(NBIX)COM64125C109$14.4K1,271,3030.1%
Tesaro IncCOM881569107$10.1K261,1300.1%
Chelsea Therapeutics International LtdCOM163428105$7.5K2,516,8700.0%
Hyperion Therapeutics IncCOM44915N101$5.7K217,5710.0%
Vanda Pharmaceuticals Inc(VNDA)COM921659108$5.4K491,0750.0%
DBV TechnologiesCOMF2927N109$5.1K480,0000.0%
Biodel IncCOM09064M105$4.0K1,281,5920.0%
Threshold Pharmaceuticals IncCOM885807206$3.2K684,0000.0%
A P Pharma IncCOM00202J203$3.0K9,067,7000.0%
Alexza Pharmaceuticals IncCOM015384100$2.0K399,9990.0%
Ophthotech CorporationCOM683745103$1.6K52,5000.0%
GTx IncCOM40052B108$1.0K500,0000.0%